News > Merger effect! Suven Pharma shares jump 15% in 2 days

Merger effect! Suven Pharma shares jump 15% in 2 days

Shares of Suven Pharmaceuticals jumped another 5% on announcing a merger with Cohance Lifesciences, which will make the joint entity a leading integrated CDMO player in India and globally. All shareholders of Cohance will be issued shares of Suven at the ratio of 11 shares of Suven for every 295 shares of Cohance, based on the swap ratio. Advent entities shall own 66.7% and the public shareholders will hold 33.3% of the combined entity.